Resources

1 Resources for

threebrothershealth.com

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb
Three Brothers Health submits: Several weeks ago, DepoMed (NASDAQ:DEPO), a specialty pharmaceutical company, announced positive phase 3 trial results for the treatment of Post Herpetic Neuralgia (‘PHN’) with DM1796. But DepoMed’s news of success was soon eclipsed. Only one week later, the company announced that Serada didn’t meet...
Tags: Biotech, Healthcare, ThreeBrothersHealth.com, DepoMed Inc.
External links 2009-11-08
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement